AJP - GI Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 288: G533-G540, 2005. First published October 14, 2004; doi:10.1152/ajpgi.00248.2004
0193-1857/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/3/G533    most recent
00248.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dixit, S. G.
Right arrow Articles by Pauletti, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dixit, S. G.
Right arrow Articles by Pauletti, G. M.

INFLAMMATION/IMMUNITY/MEDIATORS

Nitric oxide mediates increased P-glycoprotein activity in interferon-{gamma}-stimulated human intestinal cells

Santosh G. Dixit,1 Basilia Zingarelli,2 Donna J. Buckley,1 Arthur R. Buckley,1 and Giovanni M. Pauletti1

1Division of Pharmaceutical Sciences, College of Pharmacy, University of Cincinnati, Cincinnati; and 2Children's Hospital Medical Center, Division of Critical Care, Cincinnati, Ohio

Submitted 3 June 2004 ; accepted in final form 10 October 2004

Patients with refractory inflammatory bowel disease (IBD) exhibit increased expression of intestinal P-glycoprotein (P-gp) as well as elevated luminal IFN-{gamma} and nitric oxide (NO) levels. Using the in vitro Caco-2 cell culture model, we investigated whether these pathological mediators associated with the etiology of IBD affect functional activity of intestinal efflux systems. IFN-{gamma} reduced cellular uptake of cyclosporin A (CysA) but not methotrexate (MTX) in a time- and concentration-dependent manner. Simultaneously, P-gp expression increased by approximately twofold. Coincubation with the inducible NO synthase inhibitor L-N6-(1-iminoethyl)lysine (L-NIL) dramatically reduced production of intracellular NO in response to IFN-{gamma} stimulus. The presence of L-NIL also abrogated the cytokine-mediated increase in P-gp expression and function suggesting that NO is required for IFN-{gamma}-mediated activation of this efflux system. Exposure of Caco-2 cells to the chemical NO donor S-nitroso-N-acetylpenicillamine (SNAP) produced a concentration-dependent decrease in intracellular CysA accumulation that was paralleled by an increase in P-gp expression. Both IFN-{gamma} and SNAP enhanced DNA binding of NF-{kappa}B, whereas inclusion of L-NIL dramatically decreased this cytokine-induced effect on NF-{kappa}B binding. These results suggest that NO mediates IFN-{gamma}-induced increase in expression and function of intestinal P-gp in the human Caco-2 cell culture model by altering DNA binding of NF-{kappa}B, which may enhance transcription of the ABCB1 gene encoding for this efflux system.

Caco-2 cells; cytokines; efflux systems; signal transduction pathways



Address for reprint requests and other correspondence: G. M. Pauletti, College of Pharmacy, Univ. of Cincinnati, 3223 Eden Ave., Cincinnati, OH 45267-0004 (E-mail:gm.pauletti{at}uc.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.